Zhejiang Risun Intelligent Technology Co.,Ltd (SHA:688215)

Verve Therapeutics Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,390	1,049	1,439	1,231	1,401	1,893
Market Cap Growth	14.92%	-27.10%	16.91%	-12.14%	-25.96%	-
Enterprise Value	3,501	1,125	1,475	1,201	1,370	1,590
Last Close Price	54.51	16.75	22.88	19.51	22.10	29.73
PE Ratio	203.78	65.58	127.61	128.33	105.71	118.60
PS Ratio	9.00	2.71	3.87	4.02	7.01	14.19
PB Ratio	6.78	2.11	2.98	2.64	3.16	4.36
P/TBV Ratio	7.62	2.37	3.33	2.91	3.35	4.60
P/OCF Ratio	-	-	-	-	-	293.70
EV/Sales Ratio	9.29	2.90	3.96	3.92	6.85	11.92
EV/EBITDA Ratio	110.12	41.08	50.99	88.33	459.04	381.06
EV/EBIT Ratio	204.54	73.25	87.19	159.35	1019.14	561.47
Debt / Equity Ratio	0.28	0.24	0.17	0.12	0.10	0.03
Debt / EBITDA Ratio	4.45	3.91	2.66	3.48	11.52	3.12
Asset Turnover	0.47	0.50	0.51	0.46	0.36	0.37
Inventory Turnover	1.43	1.72	1.82	2.04	2.57	2.74
Quick Ratio	1.08	1.22	1.16	1.27	1.71	4.08
Current Ratio	1.84	1.87	1.82	1.86	2.33	4.55
Return on Equity (ROE)	3.94%	3.85%	3.24%	2.70%	3.33%	5.78%
Return on Assets (ROA)	1.35%	1.24%	1.45%	0.71%	0.15%	0.49%
Return on Capital (ROIC)	1.74%	1.63%	1.94%	0.93%	0.18%	0.60%
Return on Capital Employed (ROCE)	3.30%	3.00%	3.50%	1.60%	0.30%	0.60%
Earnings Yield	0.49%	1.52%	0.78%	0.78%	0.95%	0.84%
FCF Yield	-1.34%	-2.95%	-4.84%	-9.99%	-7.16%	-1.70%
Dividend Yield	0.15%	0.50%	0.28%	0.39%	0.43%	0.32%
Payout Ratio	47.03%	46.67%	56.62%	79.91%	51.80%	4.28%
Buyback Yield / Dilution	0.12%	-0.65%	1.30%	0.52%	-20.84%	-10.82%
Total Shareholder Return	0.28%	-0.15%	1.58%	0.92%	-20.40%	-10.50%

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.